These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37078466)

  • 41. Phenotypic characterization of a mouse model of juvenile neuronal ceroid lipofuscinosis.
    Katz ML; Johnson GS; Tullis GE; Lei B
    Neurobiol Dis; 2008 Feb; 29(2):242-53. PubMed ID: 17962032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative transcriptomics reveals mechanisms underlying cln3-deficiency phenotypes in Dictyostelium.
    Huber RJ; Mathavarajah S
    Cell Signal; 2019 Jun; 58():79-90. PubMed ID: 30771446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of PPARα Exhibits Therapeutic Efficacy in a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis.
    Jana M; Dutta D; Poddar J; Pahan K
    J Neurosci; 2023 Mar; 43(10):1814-1829. PubMed ID: 36697260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3).
    Aldrich A; Bosch ME; Fallet R; Odvody J; Burkovetskaya M; Rama Rao KV; Cooper JD; Drack AV; Kielian T
    Ann Neurol; 2016 Dec; 80(6):909-923. PubMed ID: 27804148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Membrane trafficking and mitochondrial abnormalities precede subunit c deposition in a cerebellar cell model of juvenile neuronal ceroid lipofuscinosis.
    Fossale E; Wolf P; Espinola JA; Lubicz-Nawrocka T; Teed AM; Gao H; Rigamonti D; Cattaneo E; MacDonald ME; Cotman SL
    BMC Neurosci; 2004 Dec; 5():57. PubMed ID: 15588329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth.
    Cotman SL; Vrbanac V; Lebel LA; Lee RL; Johnson KA; Donahue LR; Teed AM; Antonellis K; Bronson RT; Lerner TJ; MacDonald ME
    Hum Mol Genet; 2002 Oct; 11(22):2709-21. PubMed ID: 12374761
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL).
    Järvelä I; Lehtovirta M; Tikkanen R; Kyttälä A; Jalanko A
    Hum Mol Genet; 1999 Jun; 8(6):1091-8. PubMed ID: 10332042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Osmoregulation of ceroid neuronal lipofuscinosis type 3 in the renal medulla.
    Stein CS; Yancey PH; Martins I; Sigmund RD; Stokes JB; Davidson BL
    Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1388-400. PubMed ID: 20219947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
    Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
    Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High resolution MRI reveals global changes in brains of Cln3 mutant mice.
    Greene ND; Lythgoe MF; Thomas DL; Nussbaum RL; Bernard DJ; Mitchison HM
    Eur J Paediatr Neurol; 2001; 5 Suppl A():103-7. PubMed ID: 11588978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altered Expression of Ganglioside Metabolizing Enzymes Results in GM3 Ganglioside Accumulation in Cerebellar Cells of a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis.
    Somogyi A; Petcherski A; Beckert B; Huebecker M; Priestman DA; Banning A; Cotman SL; Platt FM; Ruonala MO; Tikkanen R
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29470438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Altered flurothyl seizure induction latency, phenotype, and subsequent mortality in a mouse model of juvenile neuronal ceroid lipofuscinosis/batten disease.
    Kriscenski-Perry E; Applegate CD; Serour A; Mhyre TR; Leonardo CC; Pearce DA
    Epilepsia; 2002 Oct; 43(10):1137-40. PubMed ID: 12366726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of Brain and Cerebrospinal Fluid from Mouse Models of the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Changes in the Lysosomal Proteome.
    Sleat DE; Wiseman JA; El-Banna M; Zheng H; Zhao C; Soherwardy A; Moore DF; Lobel P
    Mol Cell Proteomics; 2019 Nov; 18(11):2244-2261. PubMed ID: 31501224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for aberrant astrocyte hemichannel activity in Juvenile Neuronal Ceroid Lipofuscinosis (JNCL).
    Burkovetskaya M; Karpuk N; Xiong J; Bosch M; Boska MD; Takeuchi H; Suzumura A; Kielian T
    PLoS One; 2014; 9(4):e95023. PubMed ID: 24736558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel mutation af Cln3 associated with delayed-classic juvenile ceroid lipofuscinois and autophagic vacuolar myopathy.
    Licchetta L; Bisulli F; Fietz M; Valentino ML; Morbin M; Mostacci B; Oliver KL; Berkovic SF; Tinuper P
    Eur J Med Genet; 2015 Oct; 58(10):540-4. PubMed ID: 26360874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dipeptidyl-peptidase I does not functionally compensate for the loss of tripeptidyl-peptidase I in the neurodegenerative disease late-infantile neuronal ceroid lipofuscinosis.
    Kim KH; Pham CT; Sleat DE; Lobel P
    Biochem J; 2008 Oct; 415(2):225-32. PubMed ID: 18570628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proteomic Analysis of Brain and Cerebrospinal Fluid from the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Potential Biomarkers.
    Sleat DE; Tannous A; Sohar I; Wiseman JA; Zheng H; Qian M; Zhao C; Xin W; Barone R; Sims KB; Moore DF; Lobel P
    J Proteome Res; 2017 Oct; 16(10):3787-3804. PubMed ID: 28792770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis.
    Vuillemenot BR; Katz ML; Coates JR; Kennedy D; Tiger P; Kanazono S; Lobel P; Sohar I; Xu S; Cahayag R; Keve S; Koren E; Bunting S; Tsuruda LS; O'Neill CA
    Mol Genet Metab; 2011 Nov; 104(3):325-37. PubMed ID: 21784683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CLN3 regulates endosomal function by modulating Rab7A-effector interactions.
    Yasa S; Modica G; Sauvageau E; Kaleem A; Hermey G; Lefrancois S
    J Cell Sci; 2020 Mar; 133(6):. PubMed ID: 32034082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current Insights in Elucidation of Possible Molecular Mechanisms of the Juvenile Form of Batten Disease.
    Shematorova EK; Shpakovski GV
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.